|
CROT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20269999964928E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00480000001058E-06 |
| Normal-vs-Stage2 |
2.041200E-01 |
| Normal-vs-Stage3 |
3.45430000048275E-07 |
| Normal-vs-Stage4 |
1.41640033035628E-11 |
| Stage1-vs-Stage2 |
2.295000E-01 |
| Stage1-vs-Stage3 |
3.058000E-01 |
| Stage1-vs-Stage4 |
1.226110E-04 |
| Stage2-vs-Stage3 |
1.041650E-01 |
| Stage2-vs-Stage4 |
9.062900E-03 |
| Stage3-vs-Stage4 |
2.568200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.09409999960297E-07 |
| Normal-vs-AfricanAmerican |
6.162400E-03 |
| Normal-vs-Asian |
2.2631996277056E-10 |
| Caucasian-vs-AfricanAmerican |
4.490400E-01 |
| Caucasian-vs-Asian |
5.176800E-03 |
| AfricanAmerican-vs-Asian |
2.157700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71001000000004E-05 |
| Normal-vs-Female |
3.92910000002189E-06 |
| Male-vs-Female |
8.517000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44470000000585E-05 |
| Normal-vs-Age(41-60Yrs) |
4.28870000002135E-06 |
| Normal-vs-Age(61-80Yrs) |
1.93880999999063E-05 |
| Normal-vs-Age(81-100Yrs) |
3.558400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.662200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.260400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.431400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.518400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.249600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.513800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.378400E-02 |
| Classical-VS-Follicular |
2.716400E-02 |
| Classical-VS-Other |
9.876400E-01 |
| Classical-VS-Normal |
1.82309999985364E-07 |
| Tall-VS-Follicular |
8.797700E-04 |
| Tall-VS-Other |
5.074200E-01 |
| Tall-VS-Normal |
1.56150004038125E-09 |
| Follicular-VS-Other |
4.992200E-01 |
| Follicular-VS-Normal |
6.414200E-02 |
| Other-VS-Normal |
3.195900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.624900E-04 |
| Normal-vs-N1 |
3.44539952124023E-10 |
| N0-vs-N1 |
3.956200E-04 |
|
|
